Influenza A virus uncoating.


Journal

Advances in virus research
ISSN: 1557-8399
Titre abrégé: Adv Virus Res
Pays: United States
ID NLM: 0370441

Informations de publication

Date de publication:
2020
Historique:
entrez: 25 4 2020
pubmed: 25 4 2020
medline: 22 10 2020
Statut: ppublish

Résumé

Influenza A virus (IAV) is an enveloped virus of the Orthomyxoviridae with a negative-sense single-stranded RNA genome. During virus cell entry, viral and cellular cues are delivered in a stepwise manner within two distinct cellular compartments-the endosomes and the cytosol. Endosome maturation primes the viral core for uncoating by cytosolic host proteins and host-mediated virus disaggregation is essential for genome import and replication in the nucleus. Recent evidence shows that two well-known cellular proteins-histone deacetylase 6 (HDAC6) and karyopherin-β2 (kapβ2)-uncoat influenza virus. HDAC6 is 1 of 11 HDACs and an X-linked, cytosolic lysine deacetylase. Under normal cellular conditions HDAC6 is the tubulin deacetylase. Under proteasomal stress HDAC6 binds unanchored ubiquitin, dynein and myosin II to sequester misfolded protein aggregates for autophagy. Kapβ2 is a member of the importin β family that transports RNA-binding proteins into the nucleus by binding to disordered nuclear localization signals (NLSs) known as PY-NLS. Kapβ2 is emerging as a universal uncoating factor for IAV and human immunodeficiency virus type 1 (HIV-1). Kapβ2 can also reverse liquid-liquid phase separation (LLPS) of RNA-binding proteins by promoting their disaggregation. Thus, it is becoming evident that key players in the management of cellular condensates and membraneless organelles are potent virus uncoating factors. This emerging concept reveals implications in viral pathogenesis, as well as, the promise for cell-targeted therapeutic strategies to block universal virus uncoating pathways hijacked by enveloped RNA viruses.

Identifiants

pubmed: 32327145
pii: S0065-3527(20)30001-4
doi: 10.1016/bs.aivir.2020.01.001
pii:
doi:

Substances chimiques

beta Karyopherins 0
HDAC6 protein, human EC 3.5.1.98
Histone Deacetylase 6 EC 3.5.1.98

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-38

Informations de copyright

© 2020 Elsevier Inc. All rights reserved.

Auteurs

Yohei Yamauchi (Y)

School of Cellular & Molecular Medicine, University of Bristol, Bristol, United Kingdom. Electronic address: yohei.yamauchi@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH